New drug combo shows promise for rare Pregnancy-Related cancer

This study tests whether combining two drugs, camrelizumab and apatinib, with standard chemotherapy can help women with a rare but aggressive pregnancy-related cancer called gestational trophoblastic neoplasia (GTN). The trial includes two groups: those with ultra high-risk GTN who have not had prior treatment, and those with high-risk GTN that has not responded to or has returned after multiple chemotherapies. Treatment continues as long as it works and side effects are manageable.